Vimarsana
Biggest News Aggregation in the World

Modulated Expression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Modulated Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Modulated Expression Today - Breaking & Trending Today

Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo - Lexicon Pharmaceuticals (NASDAQ:LXRX) - Vimarsana News

Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo - Lexicon Pharmaceuticals (NASDAQ:LXRX)

THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport

Amarin Corporation plc: Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC - Vimarsana News

Amarin Corporation plc: Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC

Presentations on Additional REDUCE-IT® Sub-Population, In-Vitro Data on EPA to Be Featured at the CongressDUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc

Amarin Corp. to Present New Data Evaluating Vascept/Vazkepa (Icosapent Ethyl) at ACC23/WCC - Vimarsana News

Amarin Corp. to Present New Data Evaluating Vascept/Vazkepa (Icosapent Ethyl) at ACC23/WCC

Presentations on Additional REDUCE-IT Sub-Population, In-Vitro Data on EPA to Be Featured at the Congress